Literature DB >> 17395711

Reproducibility in protein profiling by MALDI-TOF mass spectrometry.

Jakob Albrethsen1.   

Abstract

BACKGROUND: Protein profiling with high-throughput sample preparation and MALDI-TOF MS analysis is a new potential tool for diagnosis of human diseases. However, analytical reproducibility is a significant challenge in MALDI protein profiling. This minireview summarizes studies of reproducibility of MALDI protein profiling and current approaches to improve its analytical performance.
METHODS: The PubMed database was searched using combinations of the following search terms: MALDI, SELDI, reproducibility, variation, precision, peak intensity, quantification, peptide, biomarkers, and proteomics. Acceptance criteria were detailed reports on the reproducibility with MALDI protein profiling and studies describing efforts to improve the analytical performance with this technology.
RESULTS: The reported intraexperiment CVs of the peak intensity vary highly between individual protein peaks, with the reported mean CV of the peak intensity varying among studies from 4% to 26%. There is additional interexperiment variation in peak intensity. Current approaches to improve the analytical performance of MALDI protein profiling include automated sample processing, extensive prefractionation strategies, immunocapture, prestructured target surfaces, standardized matrix (co)crystallization, improved MALDI-TOF MS instrument components, internal standard peptides, quality-control samples, replicate measurements, and algorithms for normalization and peak detection.
CONCLUSIONS: Further evaluation and optimization of MALDI-TOF MS is recommended before use in routine analysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395711     DOI: 10.1373/clinchem.2006.082644

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  54 in total

Review 1.  Screening for colorectal cancer: established and emerging modalities.

Authors:  Nikhil Pawa; Tan Arulampalam; John D Norton
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-01       Impact factor: 46.802

2.  Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling.

Authors:  Simone Nicolardi; Magnus Palmblad; Hans Dalebout; Marco Bladergroen; Rob A E M Tollenaar; André M Deelder; Yuri E M van der Burgt
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-12       Impact factor: 3.109

3.  Proteomic analysis of 3T3-L1 preadipocytes having a higher cell proliferation rate after treatment with low-molecular-weight silk fibroin peptides.

Authors:  G Huang; G Li; H Chen; Y He; Q Yao; K Chen
Journal:  Cell Prolif       Date:  2010-10       Impact factor: 6.831

Review 4.  Quantitative matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  Mark W Duncan; Heinrich Roder; Stephen W Hunsucker
Journal:  Brief Funct Genomic Proteomic       Date:  2008-09

Review 5.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.

Authors:  Andrew E Clark; Erin J Kaleta; Amit Arora; Donna M Wolk
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 6.  Proteomics of human neurodegenerative diseases.

Authors:  Jing Zhang; C Dirk Keene; Catherine Pan; Kathleen S Montine; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

7.  Optimizing High-Resolution Mass Spectrometry for the Identification of Low-Abundance Post-Translational Modifications of Intact Proteins.

Authors:  Lisa E Kilpatrick; Eric L Kilpatrick
Journal:  J Proteome Res       Date:  2017-08-08       Impact factor: 4.466

Review 8.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

9.  Assessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery.

Authors:  Ediri Sideso; Michalis Papadakis; Cynthia Wright; Ashok Handa; Alastair Buchan; Benedikt Kessler; James Kennedy
Journal:  Transl Stroke Res       Date:  2010-08-14       Impact factor: 6.829

Review 10.  Quality assessment for clinical proteomics.

Authors:  David L Tabb
Journal:  Clin Biochem       Date:  2012-12-12       Impact factor: 3.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.